Literature DB >> 2474577

Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities.

F Perosa1, S Ferrone.   

Abstract

Hybridization of murine myeloma cells P3-X63-Ag8.653 with splenocytes from a BALB/c mouse immunized with the syngeneic anti HLA-DR1,4,w6,w8,w9 MAb AC1.59 resulted in the development of 108 hybridomas secreting antiidiotypic antibodies. 100 of them inhibited the binding of MAb AC1.59 to target cells. Detailed analysis of the antiidiotypic MAb F5-444, F5-830, F5-963, F5-1126, F5-1336, and F5-1419 showed that all of them recognize idiotopes within or spatially close to the antigen combining site of MAb AC1.59. In cross-blocking experiments, the six antiidiotypic MAbs cross-blocked each other. It is likely that the six MAbs recognize spatially close, but not identical idiotopes because they elicited antiantiidiotypic antibodies of different or similar, but not identical specificity and differ in their ability to elicit anti-HLA class II antibodies. The latter, which were found only in sera from BALB/c mice immunized with antiidiotypic MAb F5-444 and F5-830, mimic the specificity of MAb AC1.59 and express the idiotope defined by the immunizing antiidiotypic MAb. These results indicate that the MAb F5-444 and F5-830 are antiidiotypes beta and the remaining four are antiidiotypes gamma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474577      PMCID: PMC329735          DOI: 10.1172/JCI114252

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.

Authors:  T Crepaldi; P Richiardi; F Malavasi; A O Carbonara; M Igarashi; S Ferrone
Journal:  Tissue Antigens       Date:  1985-07

2.  Studies of monoclonal antibodies specific for major histocompatibility complex products of the rat. III. Production and characterization of syngeneic and allogeneic monoclonal anti-idiotypic antibodies to monoclonal alloantibodies.

Authors:  S Hemmi; M Fenner; H Binz; K Winterhalter; H Wigzell
Journal:  Scand J Immunol       Date:  1985-06       Impact factor: 3.487

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Re.: Purification of IgG monoclonal antibody by caprylic acid precipitation.

Authors:  C Russo; L Callegaro; E Lanza; S Ferrone
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells.

Authors:  C Russo; A K Ng; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Idiotypic analysis of anti-I-Ak monoclonal antibodies. I. Production and characterization of syngeneic anti-idiotypic mAb against an anti-I-Ak mAb.

Authors:  M L Phillips; J F Harris; T L Delovitch
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

7.  Specific suppression of the antibody response by antibodies to receptors.

Authors:  H Cosenza; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

8.  Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation.

Authors:  M C Turco; M De Felice; L Corbo; G Morrone; R Mertelsmann; S Ferrone; S Venuta
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Idiotypic and fluorometric analysis of the antibodies that distinguish the lesion of the I-A mutant B6.C-H-2bm12.

Authors:  M R Melino; S L Epstein; D H Sachs; T H Hansen
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

10.  Suppression of idiotypic specificities in adult mice by administration of antiidiotypic antibody.

Authors:  D A Hart; A L Wang; L L Pawlak; A Nisonoff
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

View more
  4 in total

1.  Diversity of anti-HLA-DR antibodies elicited by distinct anti-idiotypic monoclonal antibodies recognizing idiotopes co-expressed by the immunizing monoclonal antibody.

Authors:  S M Mariani; E A Armandola; S Ferrone
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

2.  Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody.

Authors:  F Perosa; S Ferrone; F Dammacco
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

Authors:  A Mittelman; Z J Chen; T Kageshita; H Yang; M Yamada; P Baskind; N Goldberg; C Puccio; T Ahmed; Z Arlin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 4.  CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.

Authors:  Elvira Favoino; Marcella Prete; Andrea Marzullo; Enrico Millo; Yehuda Shoenfeld; Federico Perosa
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.